Evidence map›Paper›PMID 24358329›Full record

ArticlePloS one2013

Momordica charantia (Bitter Melon) reduces obesity-associated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues.

Bin Bao, Yan-Guang Chen, Lei Zhang, Yan Lin Na Xu, Xin Wang, Jian Liu, Wei Qu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. The metabolic effect ofFrontiers in nutrition · 2023
    Pooled it
  2. Article
  3. Multidimensional Uses of Bitter Melon (Current organic synthesis · 2025
    Review
  4. Review
  5. Promising roles ofJournal of agriculture and food research · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Transcriptome and metabolome changes induced by bitter melon (Journal of traditional and complementary medicine · 2022
    Article
  11. Article
  12. JD419, aFrontiers in microbiology · 2021
    Article
  13. The Effect ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Review
  14. Molecules (Basel, Switzerland) · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bin BaoSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Yan-Guang ChenSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Lei ZhangSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Yan Lin Na XuSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Xin WangSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Jian LiuSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Wei QuSchool of Biotechnology and Food Engineering, Hefei University of Technology, Hefei, China.
Hefei University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a world-wide epidemic disease that correlates closely with type 2 diabetes and cardiovascular diseases. Obesity-induced chronic adipose tissue inflammation is now considered as a critical contributor to the above complications. Momordica charantia (bitter melon, BM) is a traditional Chinese food and well known for its function of reducing body weight gain and insulin resistance. However, it is unclear whether BM could alleviate adipose tissue inflammation caused by obesity. In this study, C57BL/6 mice were fed high fat diet (HFD) with or without BM for 12 weeks. BM-contained diets ameliorated HFD-induced obesity and insulin resistance. Histological and real-time PCR analysis demonstrated BM not only reduced macrophage infiltration into epididymal adipose tissues (EAT) and brown adipose tissues (BAT). Flow cytometry show that BM could modify the M1/M2 phenotype ratio of macrophages in EAT. Further study showed that BM lowered mast cell recruitments in EAT, and depressed pro-inflammatory cytokine monocyte chemotactic protein-1 (MCP-1) expression in EAT and BAT as well as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) expression in EAT. Finally, ELISA analysis showed BM-contained diets also normalized serum levels of the cytokines. In summary, in concert with ameliorated insulin resistance and fat deposition, BM reduced adipose tissue inflammation in diet-induced obese (DIO) mice.

Indexed as

DietAdipose TissueAdiposityAnimalsCytokinesInflammation MediatorsInsulin ResistanceMacrophagesMaleMast CellsMiceMomordica charantiaObesityPhenotypeCytokinesInflammation Mediators

Identifiers

PMID24358329
PMCPMC3866167
OpenAlexW1965052750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.